Cambridge, MA, United States of America

Vienna Mott

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vienna Mott: Innovator in Tumor-Immune Microenvironment Modeling

Introduction

Vienna Mott is a distinguished inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of microfluidic devices for cancer research. Her innovative work focuses on creating models that simulate the tumor-immune microenvironment, which is crucial for understanding cancer dynamics.

Latest Patents

Vienna Mott holds a patent for a "Multiwell dynamic model for a tumor-immune microenvironment." This microfluidic device is designed to model a tumor-immune microenvironment and includes a multiwell plate that defines multiple microenvironment units fluidically connected to various wells. Each unit features compartments with trapping mechanisms that restrict the movement of tissue samples while allowing fluid to flow past them. The device is equipped with micropumps that control the movement of fluid samples, enhancing the study of tumor interactions with immune cells.

Career Highlights

Vienna Mott is currently employed at the Charles Stark Draper Laboratory, Inc., where she continues to advance her research in microfluidics and cancer modeling. Her work has the potential to revolutionize how researchers study tumor behavior and immune responses, paving the way for new therapeutic strategies.

Collaborations

Vienna collaborates with notable colleagues, including Jeffrey T. Borenstein and Nathan Francis Moore. Their combined expertise contributes to the innovative research environment at the Draper Laboratory.

Conclusion

Vienna Mott is a pioneering inventor whose work in microfluidic devices is making significant strides in cancer research. Her contributions are vital for advancing our understanding of tumor-immune interactions and developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…